More recently, Ab-based inhibition of MICA and MICB shedding promoted anti-tumour immunity through the activation of NK cells through dual stimulation of the NKG2D and CD16 Fc receptor pathways [149]. This evidence concerns the gene FCGR3A and neoplasm.